Preclinical research

Breaking new ground in modern drug discovery

Explore our Open Innovation preclinical research opportunities

We are making available preclinical molecules, including next generation therapeutic modalities, and our innovation discovery platforms to advance target discovery and drug development. We are seeking your help to unlock their full potential, gathering new ideas to expand their use across unknown disease pathways and targets.

Through Open Innovation, we were able to access AstraZeneca’s phenotypic library. We not only identified active compounds for known targets but also discovered new molecules with unknown mechanisms within the disease pathway.

 

Professor Cecilia Rodrigues, Faculty of Pharmacy, University of Lisbon, Portugal

Modal Window Component Section Begins
Modal Window Component Section Ends